Carlyle revives US$1.2b sale of lingerie firm Hunkemoller: sources
[AMSTERDAM] US private equity firm Carlyle is reviving plans to sell Netherlands-based lingerie chain Hunkemoller that were delayed by the pandemic, two people close to the matter told Reuters, in a deal that could top one billion euros (S$1.58 billion).
Hunkemoller, which runs 850 stores around Europe, reported earnings before interest, taxes, depreciation and amortisation (Ebitda) of 40.6 million euros in the year ended Jan 31, compared with 75.5 million euros a year earlier, before the pandemic struck. Sales fell 14 per cent to 459 million euros.
Sales and Ebitda are expected to rebound strongly this financial year, a person familiar with the matter said, as the chain has increasingly moved to a hybrid model, with online sales now making up more than a quarter of the total.
The brand, showcased by models Duckie Thot and Rebecca Mir, is also growing its wholesaling channels via Zalando, Nordstrom, Amazon and others.
The company is targeting Ebitda of 85-90 million euros this fiscal year and more than 100 million euros in 2022-2023.
JPMorgan has been picked to lead the sales process. At a valuation of 11-13 times Ebitda, the company's value is estimated around one billion euros.
A NEWSLETTER FOR YOU
Lifestyle
Our picks of the latest dining, travel and leisure options to treat yourself.
The range was derived by comparisons to recent sales of two smaller chains - Honey Birdette of Australia to Playboy owner PLBY Group in June for $333 million, and Britain's Sweaty Betty to Wolverine World Wide Inc. in August for US$410 million.
Carlyle purchased Hunkemoller for around 440 million euros in early 2016, Reuters reported at the time.
JPMorgan is expected to launch the sales process this month, month, with non-binding bids due in October, the people said.
Carlyle and JPMorgan declined to comment.
REUTERS
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
US FDA approves Pfizer’s gene therapy for rare bleeding disorder
EU toughens rules on Chinese fashion retailer Shein
Shareholders raise questions over dividend payout, directors’ salaries at Best World AGM ahead of proposed privatisation
‘Extreme’ climate blamed for world’s worst wine harvest in 62 years
Sheng Siong Q1 net profit up 9.3% on higher revenue
Nestle sales growth sputters on US slump, vitamin snags